Patents by Inventor Esther Priel

Esther Priel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Telomerase activating compounds for use in fertility and related applications
    Patent number: 11857516
    Abstract: The present invention is directed to methods and uses of a series of compounds and compositions comprising the same for treating diseases, disorders and/or conditions related to fertility and preserving same and conditions related to same. In some aspects, the compounds and or compositions as herein described promote, improve, recover or restore fertility in a subject in need thereof, including in male and/or female subjects. Such methods/uses include promoting, enhancing or improving fertility-associated cell or tissue yield as part of an in vitro fertilization protocol.
    Type: Grant
    Filed: February 12, 2018
    Date of Patent: January 2, 2024
    Assignee: Neuromagen Pharma, Ltd.
    Inventor: Esther Priel
  • TELOMERASE ACTIVATING COMPOUNDS FOR USE IN FERTILITY AND RELATED APPLICATIONS
    Publication number: 20190350878
    Abstract: The present invention is directed to methods and uses of a series of compounds and compositions comprising the same for treating diseases, disorders and/or conditions related to fertility and preserving same and conditions related to same. In some aspects, the compounds and or compositions as herein described promote, improve, recover or restore fertility in a subject in need thereof, including in male and/or female subjects. Such methods/uses include promoting, enhancing or improving fertility-associated cell or tissue yield as part of an in vitro fertilization protocol.
    Type: Application
    Filed: February 12, 2018
    Publication date: November 21, 2019
    Applicant: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
    Inventor: Esther PRIEL
  • Telomerase activating compounds and methods of use thereof
    Patent number: 10214481
    Abstract: The present invention is directed to use of a series of compounds and compositions comprising the same for activating telomerase and treating diseases, disorders and/or conditions related thereto.
    Type: Grant
    Filed: May 8, 2017
    Date of Patent: February 26, 2019
    Assignee: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AITHORITY
    Inventor: Esther Priel
  • Compounds for the treatment of diabetes and disease complications arising from same
    Patent number: 10111880
    Abstract: The present invention is directed to use of a series of tri-aryl compounds and compositions comprising the same for the treatment of diabetes and disease conditions arising as a consequence of the same.
    Type: Grant
    Filed: November 4, 2014
    Date of Patent: October 30, 2018
    Assignee: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
    Inventor: Esther Priel
  • TRI-ARYL COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME
    Publication number: 20170305836
    Abstract: The present invention relates to a novel class of tri-aryl compounds, compositions comprising the same and processes for the preparation thereof.
    Type: Application
    Filed: May 8, 2017
    Publication date: October 26, 2017
    Inventors: Esther PRIEL, Aviv GAZIT, Shimon SLAVIN, Sara YITZCHAK
  • TELOMERASE ACTIVATING COMPOUNDS AND METHODS OF USE THEREOF
    Publication number: 20170305837
    Abstract: The present invention is directed to use of a series of compounds and compositions comprising the same for activating telomerase and treating diseases, disorders and/or conditions related thereto.
    Type: Application
    Filed: May 8, 2017
    Publication date: October 26, 2017
    Inventor: Esther PRIEL
  • Telomerase activating compounds and methods of use thereof
    Patent number: 9670139
    Abstract: The present invention is directed to use of a series of compounds and compositions comprising the same for activating telomerase and treating diseases, disorders and/or conditions related thereto.
    Type: Grant
    Filed: December 17, 2013
    Date of Patent: June 6, 2017
    Assignee: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
    Inventors: Aviv Gazit, Shimon Slavin, Esther Priel, Sara Yitzchak
  • Telomerase activating compounds and methods of use thereof
    Patent number: 9670138
    Abstract: The present invention is directed to use of a series of compounds and compositions comprising the same for activating telomerase and treating diseases, disorders and/or conditions related thereto.
    Type: Grant
    Filed: November 12, 2013
    Date of Patent: June 6, 2017
    Assignee: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
    Inventor: Esther Priel
  • Tri-aryl compounds and compositions comprising the same
    Patent number: 9663448
    Abstract: The present invention relates to a novel class of tri-aryl compounds, compositions comprising the same and processes for the preparation thereof.
    Type: Grant
    Filed: November 1, 2013
    Date of Patent: May 30, 2017
    Assignee: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
    Inventors: Esther Priel, Aviv Gazit, Shimon Slavin, Sara Yitzchak
  • Compounds for the Treatment of Diabetes and Disease Complications Arising from Same
    Publication number: 20160263124
    Abstract: The present invention is directed to use of a series of tri-aryl compounds and compositions comprising the same for the treatment of diabetes and disease conditions arising as a consequence of the same.
    Type: Application
    Filed: November 4, 2014
    Publication date: September 15, 2016
    Inventor: Esther PRIEL
  • TELOMERASE ACTIVATING COMPOUNDS AND METHODS OF USE THEREOF
    Publication number: 20140142067
    Abstract: The present invention is directed to use of a series of compounds and compositions comprising the same for activating telomerase and treating diseases, disorders and/or conditions related thereto.
    Type: Application
    Filed: November 12, 2013
    Publication date: May 22, 2014
    Applicant: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
    Inventors: Aviv GAZIT, Shimon SLAVIN, Esther PRIEL, Sara YITZCHAK
  • TELOMERASE ACTIVATING COMPOUNDS AND METHODS OF USE THEREOF
    Publication number: 20140142068
    Abstract: The present invention is directed to use of a series of compounds and compositions comprising the same for activating telomerase and treating diseases, disorders and/or conditions related thereto.
    Type: Application
    Filed: December 17, 2013
    Publication date: May 22, 2014
    Applicant: Ben-Gurion University of the Negev Research and Development Authority
    Inventors: Aviv GAZIT, Shimon SLAVIN, Esther PRIEL, Sara YITZCHAK
  • TRI-ARYL COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME
    Publication number: 20140107336
    Abstract: The present invention relates to a novel class of tri-aryl compounds, compositions comprising the same and processes for the preparation thereof.
    Type: Application
    Filed: November 1, 2013
    Publication date: April 17, 2014
    Applicant: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
    Inventors: Esther PRIEL, Aviv GAZIT, Shimon SLAVIN, Sara YITZCHAK
  • Telomerase activating compounds and methods of use thereof
    Patent number: 8609736
    Abstract: The present invention is directed to use of a series of compounds and compositions comprising the same for activating telomerase and treating diseases, disorders and/or conditions related thereto.
    Type: Grant
    Filed: June 4, 2008
    Date of Patent: December 17, 2013
    Assignee: Ben-Gurion University of the Negev Research and Development Authority
    Inventors: Aviv Gazit, Shimon Slavin, Esther Priel, Sara Yitzchak
  • Tri-aryl compounds and compositions comprising the same
    Patent number: 8604245
    Abstract: The present invention relates to a novel class of tri-aryl compounds, compositions comprising the same and processes for the preparation thereof.
    Type: Grant
    Filed: June 3, 2008
    Date of Patent: December 10, 2013
    Assignee: Ben-Gurion University of the Negev Research and Development Authority
    Inventors: Esther Priel, Aviv Gazit, Shimon Slavin, Sara Yitzchak
  • TELOMERASE ACTIVATING COMPOUNDS AND METHODS OF USE THEREOF
    Publication number: 20100267667
    Abstract: The present invention is directed to use of a series of compounds and compositions comprising the same for activating telomerase and treating diseases, disorders and/or conditions related thereto.
    Type: Application
    Filed: June 4, 2008
    Publication date: October 21, 2010
    Applicant: Ben-Gurion University of the Negev Research and Development Authority
    Inventors: Aviv Gazit, Shimon Slavin, Esther Priel, Sara Yitzchak
  • TRI-ARYL COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME
    Publication number: 20100256382
    Abstract: The present invention relates to a novel class of tri-aryl compounds, compositions comprising the same and processes for the preparation thereof.
    Type: Application
    Filed: June 3, 2008
    Publication date: October 7, 2010
    Applicant: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITKY
    Inventors: Esther Priel, Aviv Gazit, Shimon Slavin, Sara Yitzchak
  • Method of treating retroviral infections in mammals
    Patent number: 5622959
    Abstract: The present invention is directed to the use of pharmaceutical compositions, containing an effective amount of topoisomerase I inhibitor such as camptothecin, useful in blocking both the initiation of infection and replication of retroviruses in host cells, thus reducing and eliminating retroviral production in infected cells. Use of such inhibitors provides as means of reducing or eliminating retroviral infections and their deleterious consequences in infected humans and animals.
    Type: Grant
    Filed: March 3, 1995
    Date of Patent: April 22, 1997
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Esther Priel, Donald G. Blair, Stephen D. Showalter
  • Method of treating retroviral infections in mammals
    Patent number: 5422344
    Abstract: The present invention is directed to the use of pharmaceutical compositions, containing an effective amount of topoisomerase I inhibitor such as camptothecin, useful in blocking both the initiation of infection and replication of retroviruses in host cells, thus reducing and eliminating retroviral production in infected cells. Use of such inhibitors provides as means of reducing or eliminating retroviral infections and their deleterious consequences in infected humans and animals.
    Type: Grant
    Filed: May 8, 1990
    Date of Patent: June 6, 1995
    Assignee: The United States of America as represented by the Secretary of the Department of Health & Human Services
    Inventors: Esther Priel, Donald G. Blair, Stephen D. Showalter